Gene · 5608
Papers2,492
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,492
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A comprehensive analysis of ncRNA-mediated interactions reveals potential prognostic biomarkers in prostate adenocarcinoma. | Comput Struct Biotechnol J | 2022 | 35891787 | PubTator, text mining | PubMed |
| Crystallographic mining of ASK1 regulators to unravel the intricate PPI interfaces for the discovery of small molecule. | Comput Struct Biotechnol J | 2022 | 35891784 | PubTator, text mining | PubMed |
| Endothelium-Dependent Induction of Vasculogenic Mimicry in Human Triple-Negative Breast Cancer Cells Is Inhibited by Calcitriol and Curcumin. | Int J Mol Sci | 2022 | 35887002 | PubTator, text mining | PubMed |
| Promising Strategies for Preserving Adult Endothelium Health and Reversing Its Dysfunction: From Liquid Biopsy to New Omics Technologies and Noninvasive Circulating Biomarkers. | Int J Mol Sci | 2022 | 35886888 | PubTator, text mining | PubMed |
| circRNA: A New Biomarker and Therapeutic Target for Esophageal Cancer. | Biomedicines | 2022 | 35884948 | PubTator, text mining | PubMed |
| Cyclic Hypoxia Induces Transcriptomic Changes in Mast Cells Leading to a Hyperresponsive Phenotype after FcεRI Cross-Linking. | Cells | 2022 | 35883682 | PubTator, text mining | PubMed |
| Comprehensive Analysis of TRP Channel-Related Genes in Patients With Triple-Negative Breast Cancer for Guiding Prognostic Prediction. | Front Oncol | 2022 | 35875096 | PubTator, text mining | PubMed |
| Crystal structure of the phosphorylated Arabidopsis MKK5 reveals activation mechanism of MAPK kinases. | Acta Biochim Biophys Sin (Shanghai) | 2022 | 35866601 | PubTator, text mining | PubMed |
| Metabolic remodeling in tumor-associated macrophages contributing to antitumor activity of cryptotanshinone by regulating TRAF6-ASK1 axis. | Mol Ther Oncolytics | 2022 | 35860009 | PubTator, text mining | PubMed |
| ZAKα-driven ribotoxic stress response activates the human NLRP1 inflammasome. | Science | 2022 | 35857590 | PubTator, text mining | PubMed |
| An in vivo model of glioblastoma radiation resistance identifies long noncoding RNAs and targetable kinases. | JCI Insight | 2022 | 35852875 | PubTator, text mining | PubMed |
| Evaluation of Transcriptomic Responses in Livers of Mice Exposed to the Short-Chain PFAS Compound HFPO-DA. | Front Toxicol | 2022 | 35832492 | PubTator, text mining | PubMed |
| Quantitative proteomic analysis shows involvement of the p38 MAPK pathway in bovine parainfluenza virus type 3 replication. | Virol J | 2022 | 35831876 | PubTator, text mining | PubMed |
| Altered Regulation of mRNA and miRNA Expression in Epithelial and Stromal Tissue of Keratoconus Corneas. | Invest Ophthalmol Vis Sci | 2022 | 35816043 | PubTator, text mining | PubMed |
| LncRNA-Mediated Adipogenesis in Different Adipocytes. | Int J Mol Sci | 2022 | 35806493 | PubTator, text mining | PubMed |
| Cellular Senescence in Age-Related Diseases: Molecular Bases and Therapeutic Interventions. | Cells | 2022 | 35805113 | PubTator, text mining | PubMed |
| Anti‑oncogenic and pro‑myogenic action of the MKK6/p38/AKT axis induced by targeting MEK/ERK in embryonal rhabdomyosarcoma. | Oncol Rep | 2022 | 35801577 | PubTator, text mining | PubMed |
| Maslinic Acid Inhibits the Growth of Malignant Gliomas by Inducing Apoptosis via MAPK Signaling. | J Oncol | 2022 | 35799612 | PubTator, text mining | PubMed |
| Long noncoding RNA MAGI2-AS3 regulates the H2O2 level and cell senescence via HSPA8. | Redox Biol | 2022 | 35797800 | PubTator, text mining | PubMed |
| CircASPH Promotes Hepatocellular Carcinoma Progression Through Methylation and Expression of HAO2. | Front Oncol | 2022 | 35795047 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5608/papers?page=16